Literature DB >> 33849480

Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.

Alex Yartsev1, Carmelle Peisah2,3.   

Abstract

BACKGROUND: Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxicity resulting from their interaction. We present a case of severe toxicity associated with the co-consumption of caffeine and Clozapine culminating in life-threatening complications requiring management in Intensive Care. CASE
PRESENTATION: A 34 year old male with a history of chronic schizophrenia, who had been managed stably on 400 mg Clozapine for the previous 5 years, changed his dietary behaviour and began consuming caffeine-containing energy drinks over the course of 3 weeks. The total daily dose of caffeine was estimated as 600 mg/day (four cans of Red Bull). He subsequently presented to the Emergency Department with life-threatening Clozapine toxicity, resulting in a decreased level of consciousness, severe metabolic acidosis, acute respiratory failure, raised inflammatory markers and acute renal failure attributed to interstitial nephritis. Maximum recorded Clozapine level was 1796 ng/ml.
CONCLUSIONS: This case describes the interaction between a common caffeine-containing beverage and a commonly prescribed antipsychotic medication, associated with severe adverse effects. We call for clinical and scientific attention to the possible interaction between these substances and draw attention to the implications for prescribing practices and patient counselling.

Entities:  

Keywords:  Caffeine; Case report; Clozapine; Interaction; Multiorgan system failure

Year:  2021        PMID: 33849480     DOI: 10.1186/s12888-021-03199-x

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   3.630


  22 in total

1.  Effect of caffeine on clozapine pharmacokinetics in healthy volunteers.

Authors:  S Hägg; O Spigset; T Mjörndal; R Dahlqvist
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

2.  Transient psychotic relapse temporally related to ingestion of an "energy drink".

Authors:  David B Menkes
Journal:  Med J Aust       Date:  2011-02-21       Impact factor: 7.738

3.  International trends in clozapine use: a study in 17 countries.

Authors:  C J Bachmann; L Aagaard; M Bernardo; L Brandt; M Cartabia; A Clavenna; A Coma Fusté; K Furu; K Garuoliené; F Hoffmann; S Hollingworth; K F Huybrechts; L J Kalverdijk; K Kawakami; H Kieler; T Kinoshita; S C López; J E Machado-Alba; M E Machado-Duque; M Mahesri; P S Nishtala; D Piovani; J Reutfors; L K Saastamoinen; I Sato; C C M Schuiling-Veninga; Y-C Shyu; D Siskind; S Skurtveit; H Verdoux; L-J Wang; C Zara Yahni; H Zoëga; D Taylor
Journal:  Acta Psychiatr Scand       Date:  2017-05-14       Impact factor: 6.392

4.  Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016).

Authors:  Shi-Wei Xu; Min Dong; Qinge Zhang; Shu-Yu Yang; Lian-Yu Chen; Kang Sim; Yan-Ling He; Helen Fk Chiu; Norman Sartorius; Chay-Hoon Tan; Mian-Yoon Chong; Naotaka Shinfuku; Shih-Ku Lin; Chee H Ng; Gabor S Ungvari; Eunice Najoan; Roy Abraham Kallivayalil; Ruzita Jamaluddin; Afzal Javed; Hitoshi Iida; Thiha Swe; Bin Zhang; Yu-Tao Xiang
Journal:  Psychiatry Res       Date:  2019-03-16       Impact factor: 3.222

5.  Clozapine levels and caffeine.

Authors:  A Odom-White; J de Leon
Journal:  J Clin Psychiatry       Date:  1996-04       Impact factor: 4.384

6.  Interaction between caffeine and clozapine.

Authors:  J L Vainer; G Chouinard
Journal:  J Clin Psychopharmacol       Date:  1994-08       Impact factor: 3.153

Review 7.  Chronic psychiatric patients' use of caffeine: pharmacological effects and mechanisms.

Authors:  A Kruger
Journal:  Psychol Rep       Date:  1996-06

8.  Caffeine consumption in hospitalized psychiatric patients.

Authors:  M Rihs; C Muller; P Baumann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

9.  Metabolism and bioactivation of clozapine by human liver in vitro.

Authors:  M Pirmohamed; D Williams; S Madden; E Templeton; B K Park
Journal:  J Pharmacol Exp Ther       Date:  1995-03       Impact factor: 4.030

10.  Dietary intervention for people with mental illness in South Australia.

Authors:  Svetlana Bogomolova; Dorota Zarnowiecki; Amy Wilson; Andrea Fielder; Nicholas Procter; Catherine Itsiopoulos; Kerin O'Dea; John Strachan; Matt Ballestrin; Andrew Champion; Natalie Parletta
Journal:  Health Promot Int       Date:  2018-02-01       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.